Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | ENPP2 | Q13822 | 2/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | CA6 | P23280 | 1/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA7 | P43166 | 1/20 | 0.38 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.38 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.38 |
| ▸ | LIPE | Q05469 | 1/20 | 0.36 |
| ▸ | ORAI1 | Q96D31 | 2/20 | 0.33 |
| ▸ | ORAI2 | Q96SN7 | 2/20 | 0.33 |
| ▸ | ORAI3 | Q9BRQ5 | 2/20 | 0.33 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.32 |
| ▸ | PCSK9 | Q8NBP7 | 1/20 | 0.32 |
| ▸ | TRPV6 | Q9H1D0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1427222 | 0.92 | MAPT (0.50) | MAPTENPP2CA4CA6CA5A | |
| SCHEMBL29875461 | 0.92 | MAPT (0.50) | MAPTENPP2CA4CA6CA5A | |
| SCHEMBL17367526 | 0.91 | MAPT (0.39) | MAPTENPP2CA4CA6CA5A | |
| SCHEMBL28995935 | 0.87 | PKM (0.41) | MAPTENPP2LIPECYP1A2KDM4E | |
| SCHEMBL29952492 | 0.87 | AKR1C3 (0.41) | MAPTCYP1A2CA1CA2KDM4E | |
| SCHEMBL26813563 | 0.87 | AKR1C3 (0.41) | MAPTCYP1A2CA1CA2KDM4E | |
| SCHEMBL29634457 | 0.86 | RAB9A (0.42) | MAPTENPP2CA4CA6CA5A | |
| SCHEMBL2163458 | 0.86 | RAB9A (0.42) | MAPTENPP2CA4CA6CA5A | |
| SCHEMBL28464197 | 0.85 | CRHBP (0.38) | MAPTENPP2LIPECYP1A2KDM4E | |
| SCHEMBL28583021 | 0.85 | MAPT (0.36) | MAPTENPP2LIPE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150380655-A1 | ANTHRACENE DERIVATIVE, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE | BOE TECHNOLOGY GROUP CO., LTD. (CN) | 2015-12-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150380655-A1 | ANTHRACENE DERIVATIVE, METHOD FOR PREPARING THE SAME, USE THEREOF AND ORGANIC LIGHT EMITTING DEVICE | ALAD, PPOX, CYBA | MAPT 2531/4885ENPP2 920/4885CA4 2344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.